Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Vaccines|September 23, 2022
The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in GermanyMichele A Kohli, Michael Maschio, Shannon Cartier, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene TherapyMichael F Drummond, Peter J Neumann, Sean D Sullivan, et al.Cost Effectiveness and Resource Allocation : C/E|July 16, 2021
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectivesZoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, et al.Cost Effectiveness and Resource Allocation : C/E|September 1, 2021
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findingsZsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2023
Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country StudyGérard de Pouvourville, David Cunningham, Frank-Ulrich Fricke, et al.Health Policy (Amsterdam, Netherlands)|November 12, 2021
Variation in market access decisions for cell and gene therapies across the United States, Canada, and EuropeSean Tunis, Eve Hanna, Peter J Neumann, et al.Journal of Market Access & Health Policy|May 27, 2026
Between Rigor and Relevance: Why the EU HTA Guidelines on Indirect Comparisons Miss the MarkSamuel Aballéa, Mondher Toumi, Piotr Wojciechowski, et al.Journal of Market Access & Health Policy|November 4, 2020
Health economic evaluation of gene replacement therapies: methodological issues and recommendationsSamuel Aballéa, Katia Thokagevistk, Rimma Velikanova, et al.Journal of Market Access & Health Policy|June 25, 2026
Supporting the Implementation and Addressing the Challenges of the EU HTA RegulationElaine Julian, Mondher Toumi, Fabrizio Gianfrate, et al.Pageof 2